Literature DB >> 25562557

Epidemiology of childhood peanut allergy.

Ashley A Dyer1, Victoria Rivkina, Dhivya Perumal, Brandon M Smeltzer, Bridget M Smith, Ruchi S Gupta.   

Abstract

Although peanut allergy is among the most common food allergies, no study has comprehensively described the epidemiology of the condition among the general pediatric population. Our objective was to better characterize peanut allergy prevalence, diagnosis trends, and reaction history among affected children identified from a representative sample of United States households with children. A randomized, cross sectional survey was administered to parents from June 2009 to February 2010. Data from 38,480 parents were collected and analyzed in regard to demographics, allergic symptoms associated with food ingestion, and methods of food allergy diagnosis. Adjusted models were estimated to examine association of these characteristics with odds of peanut allergy. Of the 3218 children identified with food allergy, 754 (24.8%) were reported to have a peanut allergy. Peanut allergy was reported most often among 6- to 10-year-old children (25.5%), white children (47.7%), and children from households with an annual income of $50,000-$99,999 (41.7%). Although peanut allergy was diagnosed by a physician in 76% of cases, significantly more peanut allergy reactions were severe as compared with reactions to other foods (53.7% versus 41.0%, p < 0.001). Parents were significantly less likely to report tolerance to peanut as compared with the odds of tolerance reported for other foods (odds ratio 0.7, 95% confidence interval: 0.5-0.9). Childhood peanut allergy, which represents nearly a quarter of all food allergy, presents more severe reactions and is least likely to be outgrown. Although it is diagnosed by a physician in nearly three-fourths of all cases, socioeconomic disparities in regard to diagnosis persist.

Entities:  

Mesh:

Year:  2015        PMID: 25562557     DOI: 10.2500/aap.2015.36.3819

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  16 in total

1.  Disorders for which the allergist-immunologist is particularly well-qualified to treat.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

2.  The asthma-chronic obstructive pulmonary disease overlap syndrome and its challenge for the allergist-immunologist.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2015 Jan-Feb       Impact factor: 2.587

3.  Blood levels of lead and mercury and celiac disease seropositivity: the US National Health and Nutrition Examination Survey.

Authors:  Elena Kamycheva; Tadahiro Goto; Carlos A Camargo
Journal:  Environ Sci Pollut Res Int       Date:  2017-02-09       Impact factor: 4.223

4.  Effect of chemical modifications on allergenic potency of peanut proteins.

Authors:  Ramon Bencharitiwong; Hanneke P M van der Kleij; Stef J Koppelman; Anna Nowak-Węgrzyn
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

5.  A mouse model of the LEAP study reveals a role for CTLA-4 in preventing peanut allergy induced by environmental peanut exposure.

Authors:  James W Krempski; Jyoti K Lama; Koji Iijima; Takao Kobayashi; Mayumi Matsunaga; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2022-03-12       Impact factor: 14.290

Review 6.  Preventing Peanut Allergy.

Authors:  Meng Chen; Michael Welch; Susan Laubach
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2018-03-01       Impact factor: 1.349

7.  Prevalence of self-reported food allergy in U.S. adults: 2001, 2006, and 2010.

Authors:  Linda Verrill; Richard Bruns; Stefano Luccioli
Journal:  Allergy Asthma Proc       Date:  2015-10-08       Impact factor: 2.587

8.  Parental Perception, Prevalence and Primary Care Physicians' Knowledge on Childhood Food Allergy in Croatia.

Authors:  Tamara Voskresensky Baricic; Marija Catipovic; Erina L Cetinic; Vlado Krmek; Ivona Horvat
Journal:  Children (Basel)       Date:  2015-07-17

9.  Omalizumab facilitates rapid oral desensitization for peanut allergy.

Authors:  Andrew J MacGinnitie; Rima Rachid; Hana Gragg; Sara V Little; Paul Lakin; Antonella Cianferoni; Jennifer Heimall; Melanie Makhija; Rachel Robison; R Sharon Chinthrajah; John Lee; Jennifer Lebovidge; Tina Dominguez; Courtney Rooney; Megan Ott Lewis; Jennifer Koss; Elizabeth Burke-Roberts; Kimberly Chin; Tanya Logvinenko; Jacqueline A Pongracic; Dale T Umetsu; Jonathan Spergel; Kari C Nadeau; Lynda C Schneider
Journal:  J Allergy Clin Immunol       Date:  2016-09-05       Impact factor: 10.793

10.  Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Allergy.

Authors:  Hye Young Kim; Youngshin Han; Kwanghoon Kim; Ji Young Lee; Min Ji Kim; Kangmo Ahn; Jihyun Kim
Journal:  Allergy Asthma Immunol Res       Date:  2015-11-02       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.